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For repair of chronic or difficult-to-heal tissue lesions and defects, major constraints exist 
to a broad application of cell therapy and tissue engineering approaches, i.e., trans-
plantation of “ex vivo” expanded autologous stem/progenitor cells, alone or associated 
with carrier biomaterials. To enable a large number of patients to benefit, new strategies 
should be considered. One of the main goals of contemporary regenerative medicine is 
to develop new regenerative therapies, inspired from Mother Nature. In all injured tissues, 
when platelets are activated by tissue contact, their released factors promote innate 
immune cell migration to the wound site. Platelet-derived factors and factors secreted 
by migrating immune cells create an inflammatory microenvironment, in turn, causing the 
activation of angiogenesis and vasculogenesis processes. Eventually, repair or regener-
ation of the injured tissue occurs via paracrine signals activating, mobilizing or recruiting 
to the wound site cells with healing potential, such as stem cells, progenitors, or undiffer-
entiated cells derived from the reprogramming of tissue differentiated cells. This review, 
largely based on our studies, discusses the identification of new tools, inspired by cellular 
and molecular mechanisms overseeing physiological tissue healing, that could reactivate 
dormant endogenous regeneration mechanisms lost during evolution and ontogenesis.
Keywords: tissue regeneration, tissue healing, platelet factors, innate immunity, angiogenesis, stem cells, cell 
reprogramming
iNTRODUCTiON
Over the last two decades, significant progresses have been made by transplantation of “ex vivo” 
expanded autologous stem/progenitor cells, mostly associated with biomaterials, for the repair of 
chronic or difficult-to-heal tissue lesions and defects caused by disease, trauma, or tumor surgery. 
Our lab was among the pioneers in applying a tissue engineering approach for repairing and recon-
structing human epithelia in burned patients (De Luca et al., 1989), as well as urethra for congenital 
malformations (Romagnoli et al., 1990), corneal epithelium in eye chemical burns (Pellegrini et al., 
1997), and long-bone defects in trauma outcome (Quarto et al., 2001). However, despite these suc-
cesses, we must acknowledge that major constraints exist for the broad application of this approach, 
2
Cancedda et al. Endogenous Repair of Tissue Defects
Frontiers in Bioengineering and Biotechnology | www.frontiersin.org April 2017 | Volume 5 | Article 28
including complexity and morbidity of surgical procedures, and 
logistics and high costs of the cell isolation and expansion in 
highly qualified structures. Therefore, it appears that “classical” 
tissue engineering should be considered only in extreme and very 
critical situations. Hence, in order to enable a large number of 
patients to benefit, new strategies should be developed. In the 
last decades, thanks to the recent progresses in chemistry, bio-
chemistry, and pharmacology, we have seen the development and 
application of a large number of drugs and devices aimed at the 
treatment of symptoms, blocking unwanted pathways and, in the 
case of infectious diseases, fighting the responsible microorgan-
isms. Nonetheless, we are currently facing a dramatic change in 
the therapeutic approach to pathologies and diseases. Indeed, the 
present and the next years challenge is to fully restore the physi-
ological status of a diseased organism and to completely regener-
ate tissue and organs when so seriously affected that treatments 
cannot be limited to the repression of symptoms. Unfortunately, 
the body self-regeneration capacity has been lost during evolu-
tion. While a fragment of planaria can generate a whole new 
individual, newts can regrow a limb, lizards their tail, crabs can 
develop a new claw, and zebrafishes can rekindle the heart, we, as 
adult humans, cannot rely on a full regeneration of a lost part of 
the body since restorative potential is limited to the human fetus 
or to a very early postnatal stage. Thankfully, evolution granted us 
with a much better brain than a planaria, a newt, a lizard, a crab, 
and a zebrafish. Thus, we must use our brain to develop products 
and procedures able to reactivate the regeneration mechanisms 
lost during evolution.
The common core concept discussed in this article, largely 
based on studies of our laboratory, focuses on the identification 
of tools to reactivate or stimulate dormant endogenous regenera-
tion mechanisms, since this probably represents the main goal of 
contemporary regenerative medicine.
eNDOGeNOUS ReGeNeRATiON
endogenous Regeneration Potential is 
Lost during Phylogeny and Ontogeny
Regeneration is the structural and functional restoration of a 
missing part of the body. Regeneration can occur at different 
levels of biological organization. The newt is able to regenerate 
the limbs throughout its lifespan. When a limb is amputated, a 
cell mass called blastema is formed at the stump from which a 
new functional limb will be shaped. The newt switches the cellular 
mechanism for limb regeneration from a stem/progenitor-based 
mechanism (larval mode) to a dedifferentiation-based one (adult 
mode) (Tanaka et al., 2016). At the larval stage, new tissues of the 
regenerated limb originate from stem/progenitor cells recruited 
to the blastema. Conversely, after metamorphosis, differentiated 
cells of the limb tissues revert to a pre-differentiation stage and 
contribute to the blastema formation, eventually giving rise to 
the fully regenerated limb. Cells from the different adult limb 
tissues, such as skin, bone, muscle, and nerves strictly regener-
ate the same kind of tissues components. Most of the other 
amphibian models, analyzed so far, regenerate limbs at the larval 
stage, but this capacity is lost after metamorphosis. However, 
stem/progenitor cells are still present in the tissues, such as satellite 
cells within the skeletal muscles. This suggests that the potential 
of stem/progenitor cells to be mobilized into the blastema is lost 
during metamorphosis. Indeed, in Xenopus laevis, it has been 
reported that the expression of hepatocyte growth factor, which 
can recruit satellite cells into the blastema, decreases during 
metamorphosis (Alvarado and Tsonis, 2006; Beck et al., 2009). An 
increasing number of experimental evidences suggest that regen-
eration recapitulates the original structure development (Nacu 
and Tanaka, 2011). For example, it has been reported that during 
limb regeneration several genes originally expressed during limb 
development are reactivated. Hence, the contemporary working 
paradigm in regenerative medicine is based on the idea that tissue 
regeneration in the adult can be strengthened by the reactivation 
of those same embryonic mechanisms that contributed to tissue 
morphogenesis in first instance.
Although mammals are unable of regenerating limbs and tails, 
a regenerative potential has been described by different authors 
in several tissues and organs of mammalian embryos and fetuses 
(Colwell et  al., 2005; Nakada et  al., 2015). Fetuses can regrow 
almost anything that gets damaged while in the womb. Instead, 
liver regeneration and the regrowth of the amputated digit tips, 
this last occurring in children in the first decade and before 
sexual maturity, are unique examples of after-birth regeneration 
in humans (Kisch et al., 2015). The mouse digit tip model imitates 
very well the endogenous regenerative response of the human 
digit tip (Simkin et al., 2013), and it was used to show the role 
played by growth factors, such as BMP2 and BMP7, present in 
the wound exudate. Interestingly, Seifert et al. (2012) reported the 
first example of a large portion of skin regeneration in mammals. 
In the African spiny mice, after a skin autotomy to elude capture 
by predators, complete skin regeneration occurs in record time. 
This may indicate that mammal regeneration may not be a distant 
hope as we had feared.
However, although cellular and molecular mechanisms of 
regeneration are currently being investigated in a variety of 
contexts (Tanaka and Reddien, 2011), our understanding of 
the epigenetic reprogramming controlling regeneration in the 
different species is only at the beginning (Katsuyama and Paro, 
2011). In humans and mice, an efficient endogenous regenerative 
response fails to occur after a substantial injury, such as a myo-
cardial infarction. On the contrary to mammals, in zebrafish, 
an amputated, cryoinjured, or infarct heart can fully regenerate 
by reactivation of cardiac progenitor cells and the dedifferen-
tiation, proliferation, and maturation of residing cardiomyocytes 
(Kikuchi et al., 2010). Aguirre et al. (2014) identified miR-99/100 
and Let-7a/c and their protein targets SMARCA5 and FNTB as 
critical regulators of cardiomyocyte dedifferentiation and heart 
regeneration in zebrafish. Despite the inability to efficiently 
activate endogenous regenerative mechanisms, the molecular 
regulators of this response are conserved in mammals. The 
manipulation of this molecular machinery in mice resulted in 
cardiomyocyte dedifferentiation and improved heart function 
after injury (Aguirre et al., 2014). Moreover, it was recently shown 
that the rodent heart still maintain full myocardial regenerative 
capacity, but strictly limited to the first week of life (Porrello et al., 
2011), possibly suggesting that such molecular machinery might 
FiGURe 1 | Main events and phases of the wound healing process.
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remain quiescent and dormant due to epigenetic differences 
among different species and/or during aging.
Lesson Learned from Regeneration  
in Different Animal Species
Basically, all organisms have the ability to regenerate something. 
This process occurs to a greater extent in lower organisms, such 
as flatworms, and in invertebrates, like starfishes and earth-
worms. Regeneration is much more limited in higher organisms. 
Although it is quite obvious that the regeneration potential is lost 
during evolution, the mechanisms by which the natural selection 
operated has not been always clear since many incongruities exist 
among close species. As an example, only earthworms, and not 
the close species leech, can replace lost parts of the body. Some 
insects can regrow lost legs, but others insect cannot. Bony fishes, 
but not cartilaginous fishes, can regenerate fins. Among amphib-
ians, salamanders and newts regenerate their legs, but frogs and 
toads do not [reviewed in Simon and Tanaka (2013)].
However, in order for regeneration to occur, there must be a 
source of blastema (undifferentiated cells) and regeneration must 
be activated by an external physiological stimulus. Undifferentiated 
cells are more abundant in the embryonic and fetal life that in 
adults and this could explain the greater regeneration potential 
of embryos and fetuses compared to adults. Alternatively, in 
adults, undifferentiated cells could derive from the remnants 
of the original structure (Tanaka et al., 2016). The physiological 
stimulus could be mediated by a nerve supply (Peadon and Singer, 
1965; Simões et al., 2014), could be molecules such as hormones 
and growth factors [reviewed in Nacu and Tanaka (2011)], or 
could depend upon an interaction between cells of different tis-
sues, including epidermal/mesenchymal interactions. It has been 
suggested that a key role in these interactions between cells of 
different tissues is played by matrix metalloproteases (MMPs) 
(Santosh et al., 2011).
Moreover, the natural selection pressure in response to other 
needs of the animal and the way by which wound heals have to be 
considered. Differences observed in amphibians could be related 
to the fact that legs are not very useful for the movements of sala-
mander and newt in water, whereas frogs and toads are depend-
ent on their legs to move. Given their size and complex structure, 
higher vertebrates have the urgent need of a rapid wound closure 
and damage repair in case of injury, and this occurs through the 
formation of a thick scar tissue to the detriment of full regenera-
tion. As an example, in a skin injury, the scar tissue could impair 
the contact between epidermis and underlying tissues which is 
required to trigger the rise of blastema like cells, key players in 
the regeneration process.
Mechanisms and Phases of Physiological 
wound Healing in Humans
To develop new regenerative therapies in humans, we should learn 
from Mother Nature and expand our knowledge about cellular 
and molecular mechanisms overseeing physiological tissue heal-
ing. Although every tissue has a specific response to healing, there 
is a common initial stage after the damage that is characterized by 
hematoma, clot formation, and platelet activation (Gurtner et al., 
2008; Nurden et al., 2008; Widgerow, 2011). Main events occur-
ring during a physiological healing are depicted in Figure 1. In all 
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tissues—apart from hyaline cartilage—upon injury, platelets form 
a plug that stabilizes the clot within a fibrin meshwork (Foster 
et al., 2009). When platelets get activated by the contact with the 
injured tissue, or by thrombin and calcium, they release a variety 
of growth factors and bioactive molecules via a degranulation 
process. Platelet released factors and molecules play a significant 
role in triggering the healing process and are crucial for regulat-
ing immune cell migration (Morrell et al., 2014). Immune cells 
and their secreted factors are key master regulators for progres-
sion of the physiological response to injury (Shi et al., 2003). In 
fact, hematoma, immune cells and their secreted factors create 
an inflammatory microenvironment, at the site of the wound, 
attracting local and circulating endothelial, mesenchymal, and 
epithelial cells (Bussolino et al., 1989; Rabbany et al., 2003; Tasso 
et al., 2013; Ulivi et al., 2014). This results in angiogenesis and vas-
culogenesis activation, i.e., new vessel formation by sprouting of 
pre-existing vessels and from recruited endothelial progenitors, 
respectively. Following this first inflammatory phase, tissue repair 
or regeneration may occur via paracrine signals mobilizing or 
recruiting, to the wound site, cells with healing potential, such as 
stem cells, progenitors, and immature cells derived from resident 
differentiated cell reprogramming.
Targeting the Tissue Repair/Regeneration 
Process by Platelet Derivatives
Given the triggering role played by platelets during tissue heal-
ing, local application of autologous platelet-rich plasma (PRP) 
has been proposed as source of factors and nutrients to treat 
chronic or acute, often severe, damages in different organ dis-
tricts. These include chronic skin ulcers (Martínez-Zapata et al., 
2009), articular cartilage damage (Dold et al., 2014), bone and 
tendon lesions (Alsousou et  al., 2009; Intini, 2009), peripheral 
nerve wound (Zheng et al., 2014), cardiac muscle injury (Vu et al., 
2015), plastic and maxillofacial applications (Marx et al., 1998; 
Martínez-Zapata et  al., 2009). PRP has also been used for the 
treatment of injuries in professional sportspersons (Taylor et al., 
2011; Dold et  al., 2014) and in racing animals (Waselau et  al., 
2008; Witte et al., 2016). The use of PRP or other platelet-derived 
components relies on the reactivation of latent endogenous 
regeneration mechanisms. In vitro experiments from our group 
demonstrated that, following an initial transient enhancement of 
the inflammatory response (NF-kB activation, COX-2 induction, 
and secretion of pro-inflammatory cytokines), PRP favored the 
establishment of an anti-inflammatory microenvironment via 
prostaglandin E2 (PGE2) production (Ruggiu et  al., 2013). An 
upregulation of the proliferative and survival pathways ERKs and 
Akt and the cell cycle reactivation in quiescent cells via induction 
of Cyclin D1 and phosphorylation of retinoblastoma was also 
observed. A 24 h treatment was sufficient to trigger all processes. 
Moreover, PRP can promote recruitment of neutrophils and 
macrophages, which, in turn, due to their paracrine activity, 
not only enhance endothelial cell recruitment and improve 
vascularization, but also attract and stimulate proliferation of 
circulating and/or locally resident mesenchymal and epithelial 
stem/progenitor cells, thus enhancing whole tissue repair (Pierce 
et  al., 1989). Interesting, PRP has also been shown to exert an 
antinociceptive activity by a peripheral endocannabinoid-related 
mechanism (Descalzi et al., 2013).
Platelet-rich plasma has the advantage of being a concentrated 
cocktail of factors, present in ideal relative proportions, and nec-
essary for healing. Among them are platelet-derived growth fac-
tors (PDGF-A and PDGF-B homo- and hetero-dimers), vascular 
endothelial growth factor (VEGF), epidermal growth factor (EGF), 
heparin binding EGF-like growth factor (HB-EGF), fibroblast 
growth factor (FGF), transforming growth factor beta (TGF-β), 
and interleukin-8 (IL-8). Notably, the expression of these factors 
is spatiotemporally regulated during wound healing. Indeed, the 
missed expression of some of these factors could delay the wound 
process (Martin, 1997; Werner and Grose, 2003; Gurtner et al., 
2008). PDGF plays a key role both at an early and a late stage 
of healing. In the early phases, PDGF recruits to the wound bed 
neutrophils, monocytes/macrophages, and participates in the 
macrophage activation. At a later stage, it stimulates pericyte and 
fibroblast recruitment and proliferation and enhances matrix 
deposition (Martin, 1997; Werner and Grose, 2003). PDGF also 
induces myofibroblast differentiation and stimulates fibroblasts to 
contract collagen fibers (Werner and Grose, 2003; Martino et al., 
2014, 2015). PDGF plays a key role also in angiogenesis and the 
combined delivery with VEGF can normalize defective angiogen-
esis (Martino et  al., 2015). VEGF-A, which is secreted in high 
amount by keratinocytes and macrophages, is a master regulator 
of physiological and pathological angiogenesis and vasculogenesis 
acting on the granulation tissue formation (Martino et al., 2014, 
2015). FGF-2, present at significant concentration in the initial 
wound fluid, stimulates wound repair by promoting fibroblast and 
endothelial cell proliferation, migration, and differentiation and 
in synergy with VEGF it also sustains angiogenesis (Werner and 
Grose, 2003; Gurtner et al., 2008). EGF induces the proliferation 
and cell migration of keratinocytes during the re-epithelialization 
process (Martin, 1997). HB-EGF is a keratinocyte and fibroblast 
mitogen and also promotes cell migration (Martin, 1997; Werner 
and Grose, 2003). TGF-β is a potent chemoattractant for neutro-
phils, macrophages, and fibroblasts and stimulates formation of 
granulation and re-epithelialization (Werner and Grose, 2003). 
IL-8 is involved in angiogenesis and re-epithelialization and 
inhibits wound contraction (Werner and Grose, 2003).
Platelet-rich plasma is usually prepared from the patient 
whole blood (autologous PRP) by separating the red blood cells 
and concentrating the platelets and other components of plasma. 
However, blood of different individuals can present a significant 
variability in platelet concentration (Weibrich et  al., 2002). 
Moreover, obtaining autologous fresh PRP from the patient’s 
blood may be unwieldy. A standardized PRP-production proce-
dure, starting from pools of human-certified buffy coats has been 
proposed to reduce PRP variability and to obtain a PRP with a 
well-defined platelet and growth factor concentration (Muraglia 
et al., 2014, 2015). Indeed, an allogenic source of platelets could 
offer further benefits including an “off the shelf,” quality con-
trolled, and safe product. In addition, this could result in the use 
of buffy coats otherwise discarded after fractionation of humani-
tarianly donated blood. Given the triggering role of platelets in 
the tissue healing process, the use of their derived compounds 
was proposed also as cell culture medium supplements. Indeed, 
5
Cancedda et al. Endogenous Repair of Tissue Defects
Frontiers in Bioengineering and Biotechnology | www.frontiersin.org April 2017 | Volume 5 | Article 28
cell cultures were exploited to investigate molecular mechanisms 
and pathways activated in cells exposed to platelet derivatives 
(Ruggiu et al., 2013; Muraglia et al., 2014, 2015). Indeed, the effect 
of the platelet lysates (PLs) on cell proliferation and differentia-
tion reprogramming was shown in different types of cells [also 
reviewed in Xie et al. (2014), Tobita et al. (2015), and Astori et al. 
(2016)].
Guiding innate immune Response, 
inflammation, and M1/M2 Macrophage 
Balance
Innate immune response molecules play an important role dur-
ing regeneration of planaria, an organism that does not have an 
adaptive immune system (Peiris et al., 2014). Instead, an adaptive 
immune system is present in salamander; nonetheless, investiga-
tions on salamander scar-free repair and regeneration revealed 
the role of factors common to the planaria innate immune system 
(Godwin and Rosenthal, 2014). Thus, innate immune signaling 
may be crucial for the migration of proper cell types to the wound 
site. In humans, studies of healing in autoimmune patients 
indicated that a proper balance of immune response must be 
maintained during wound repair (Loots et al., 1998). Other stud-
ies suggested that a more developed immune system may be the 
cause of scaring and of a reduced regenerative capacity during 
wound repair (Peiris et al., 2014).
Neutrophils are the first inflammatory cells recruited to the 
wound site. They are chemoattracted by factors supplied by 
platelets, such as VEGF-A, and by the hypoxic microenvironment 
(de Oliveira et al., 2016). In the complex interplay represented by 
the wound healing niche, neutrophils are not only necessary to 
“clean” the injured area from bacteria and apoptotic cells but also 
to produce cytokines, growth factors, and other soluble mediators 
activating other cells present in the wound (Wilgus et al., 2013).
Monocytes, being the second wave of recruited cells, can be 
considered the most relevant immune cell population in the 
wound healing niche. Monocyte depletion impairs the repair/
regenerative processes with a significant delay in wound healing 
parameters, including epithelialization and decreased neovas-
cularization (van Amerongen et al., 2007; Brancato and Albina, 
2011). Resident macrophages are a little fraction compared to 
macrophages derived from monocytes recruited to the wound 
site from the peripheral blood (PB). There are two main types 
of macrophages, namely, M1 and M2 (Murray et al., 2014). M1 
macrophages (sometimes referred to as classically activated or 
pro-inflammatory macrophages) are characterized by iNOS 
expression, high level of IL-12, and low level of IL-10 secretion. 
M2 macrophages (also referred to as alternatively activated or 
anti-inflammatory macrophages) secrete high levels of IL-10 
and TGF-β, low levels of IL-12, and express Arginase I, as well 
as multiple receptors, such as CD163, CD206, RAGE, and other 
scavenger receptors (Rath et  al., 2014). M2 macrophages con-
tribute to quench the inflammatory phase during healing via the 
release of anti-inflammatory molecules (Mantovani et al., 2013). 
A population of cardiac macrophages as mediators of heart repair 
and regeneration was identified after a myocardial infarction in 
1-day-old neonatal mice (Aurora et al., 2014).
Recent findings indicate that macrophages are not just par-
ticipants, but are coordinators of early wound healing events. 
Indeed, the sequential activation of macrophages to M1 and M2 
phenotype orchestrate adult tissue regeneration and support 
the concept that inflammation, through macrophage activation, 
controls tissue precursor cell fate and coordinates tissue repair 
(Saclier et al., 2013; Das et al., 2015). In this context, we investi-
gated the effect of the medium conditioned by mesenchymal stem 
cells (MSCs), previously exposed to a wound microenvironment, 
in promoting the macrophage polarization from an M1 to an M2 
phenotype. Before the medium collection, MSCs were stimu-
lated by molecules released by platelets and pro-inflammatory 
cytokines, the two main players at the onset of the wound healing 
process. This led to a progressively increasing concentration of 
PGE2 in the MSC medium, promoting the macrophage switch 
from a pro-inflammatory to an anti-inflammatory phenotype 
(Tasso et  al., 2013; Ulivi et  al., 2014). Moreover, other authors 
reported that a platelet supernatant suppressed the inflammatory 
responses of bone marrow-derived macrophages via negative 
regulation of NF-kB signaling, overall leading to lowered expres-
sion of iNOS and enhanced l-arginine catabolism by Arginase-1 
(Ando et al., 2016). Additional in vitro experiments of our group 
showed that, during the initial enhancement of the inflammatory 
phase, PRP polarizes the monocyte differentiation also toward an 
anti-inflammatory subset of dendritic cells with some similari-
ties to M2 macrophages thus giving additional evidence of PRP 
ability to modify the wound healing microenvironment (Papait 
et al., 2016).
Supporting Neovascularization Phase 
during the Healing Process
The inflammatory phase is followed by a proliferation phase 
beginning with the formation of a granulation tissue. Granulation 
tissue, i.e., the combination of a new undifferentiated connective 
tissue and tiny blood vessels, forms on the wound surface and 
fills wounds of almost any size. New vessel formation, eventually 
leading to the restoration of the vascular network, can occur by (i) 
angiogenesis, i.e., the formation of new vessels through the sprout-
ing of the pre-existing vessels, or by (ii) vasculogenesis, i.e., the 
formation of new vessels through the recruitment of endothelial 
progenitors circulating in the PB (Velazquez, 2007; Olfert et al., 
2016). In both cases, the new vessels must be stabilized through 
the association of cells of mesenchymal origin, namely, pericytes, 
otherwise, they are rapidly resorbed within few days from their 
formation (Armulik et al., 2011).
The changes occurring within the wound site during the first 
days after injury promote both types of processes. The initial 
inflammatory microenvironment stimulates recruitment, adhe-
sion, and homing of endothelial progenitors forming endothelial 
cell tubular structures first, and then of smooth muscle cells and 
pericytes wrapping around the endothelial cells, thus contribut-
ing to the newly formed capillary maturation and stabilization. 
In particular, platelets and innate immunity cell secretome are 
enriched of factors acting on endothelial cells of pre-existing 
vessels, hence activating endothelial cell proliferation and expres-
sion of proteases—mainly MMPs such as MT-MMP1—digesting 
the surrounding extracellular matrix to allow migration of the 
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proliferating endothelial cells and formation of vessel sprouts 
connecting to other vessels. At this time, a critical microenviron-
ment change is represented by the O2 supply reduction resulting in 
the activation of hypoxia-inducible factors, which in turn induce 
the expression of master angiogenesis regulating factors, includ-
ing VEGF, and the FGF family, in particular FGF-1 and FGF-2 
(Krock et  al., 2011). Other factors playing a major role at this 
stage are Angiopoietins 1 and 2, Class 3 Semaphorins, members 
of the TGF-β superfamily, and the PDGF, which is also secreted 
by endothelial cells and promotes the migration of pericytes to 
the growing capillaries.
Sometimes angiogenesis can occur through a less understood 
mechanism named “splitting angiogenesis,” where a new vessel is 
formed by the splitting of a pre-existing blood vessel in two (Olfert 
et al., 2016). This allows an increase in the number of capillaries 
without necessarily a corresponding increase in the number of 
endothelial cells and could possibly be more energy-efficient than 
sprouting (Ji et al., 2006).
exploiting Stem and Progenitor Cell 
Secretome and Released extracellular 
vesicles for Regenerative Purposes
Until recently, stem cell therapy for tissue regeneration was based 
on the assumption that transplanted stem cells could directly 
contribute by transdifferentiation to the new tissue formation. 
However, an increasing body of experimental evidences suggests 
that the benefits obtained following stem cell implantation are 
mostly related to their paracrine activity, rather than a direct 
involvement in the tissue replacement. As result of this change 
in perspective, several studies are now specifically focusing on 
the stem cell secretome, as the whole of soluble paracrine factors, 
including growth factors, cytokines, and chemokines that the 
cells can release locally, thus contributing to the positive ending 
of the healing process.
In this scenario, our group was interested in characterizing 
the potential as regeneration inducer of the secretome fetal stem 
cells, such as the c-kit + human amniotic fluid stem cells (hAFS). 
Indeed, being fetal stem cells developmentally much younger and 
more immature compared to adult ones, and harboring a stronger 
proliferative potential, hAFS may represent an ideal source to 
exploit for future therapy (De Coppi et  al., 2007). We showed 
that hAFS enhanced tissue repair by recruiting host progenitor 
cells at the site of in vivo transplantation (Mirebella et al., 2011). 
Moreover, hAFS secreted discrete paracrine angiogeneic factors, 
such as VEGF, IL-8, MCP-1, and SDF-1, triggering neoangiogen-
esis and sustaining tissue regeneration in a rat hind-limb ischemic 
model (Teodelinda et al., 2011). These encouraging results were 
further confirmed in a rat model of ischemic full-thickness skin 
flap elevated on the epigastric region, where the hAFS secretome 
induced both the activation of the local resident endothelial 
cells and the recruitment of endothelial progenitor cells (EPCs) 
(Mirabella et al., 2012). The powerful paracrine potential of AFS 
was also demonstrated by other independent studies, show-
ing that fetal cells improved survival and clinical outcome in a 
preclinical rat model of necrotizing enterocolitis, decreased gut 
damage, and improved tissue structure and function mainly via 
in  situ paracrine effects (Zani et  al., 2014). Moreover, mouse 
GFP + AFS, injected in a chronic mouse model of skeletal muscle 
atrophy, enhanced muscle strength and improved the survival 
rate of the affected animals while restoring the muscle niche pos-
sibly via modulatory influence (Piccoli et al., 2012).
The adult mammalian heart has a very limited repair capac-
ity when facing severe injury, congenital defects, or aging. 
This is due to a combination of tissue intrinsic causes, such as 
poor cardioprotection, defective repair, and extremely limited 
myocardial renewal potential. Benefits resulting from stem cell 
transplantation were observed by different authors, although 
controversial results were also reported (Toma et  al., 2002; 
Murry et al., 2004; Wei et al., 2012). Indeed, the healing effects 
obtained following stem cell therapy were mainly explained as 
the result of the transplanted cell paracrine activity counteract-
ing cardiovascular cell apoptosis and fibrosis, while modulating 
inflammation, improving neoangiogenesis, activating cardiac 
progenitor resident cells, and significantly improving cardiac 
function. In some initial studies, adult MSCs were transplanted 
(Gnecchi, 2006; Noiseux et al., 2006; Hatzistergos et al., 2010). 
However, a recent study showed that implanted hAFS exerted a 
remarkable cardioprotective influence on the ischemic heart of 
rats undergoing ischemia/reperfusion injury and, within 2  h, 
dramatically reduced the infarct size, suggesting a paracrine 
activity of the implanted cells. This hypothesis was confirmed by 
injecting the cell-conditioned medium (Bollini et al., 2011) and 
showing that the hAFS secretome was enriched with cardioactive 
factors, among which the small peptide thymosin beta 4, a well-
known master regulator of epicardial progenitor cells activation 
(Smart et al., 2012) as well as a powerful cardioprotective agent 
(Bock-Marquette et al., 2004). More recently, our group charac-
terized the cardioprotective mechanisms of the hAFS secretome 
also in a chemotherapy-derived model of cardiotoxicity. Indeed, 
the paracrine factors within the medium conditioned by hAFS 
prestimulated by a hypoxic environment exposure significantly 
counteracted doxorubicin-induced premature senescence and 
apoptosis of cardiomyocytes and cardiac progenitor cells, by 
inducing on the target cells an autocrine feedback based on pro-
duction of pro-survival chemokines and cytokines consequent to 
the activation of the pAkt/PI3K pathway (Lazzarini et al., 2016).
Also transplanted adult MSCs were shown to exert a remark-
ably beneficial effect in different injury models, regardless of their 
poor in  vivo engraftment and long-term differentiation. This 
therapeutic effect, mediated by MSC paracrine activity (Prockop 
and Oh, 2012; Kean et al., 2013), was exploited in a variety of pre-
clinical models, among the others the myocardial infarction, the 
hind-limb ischemia, and the acute renal failure (Heederik et al., 
1992; Gnecchi et al., 2005; Tögel et al., 2005). The relevance of 
the MSC paracrine potential inspired the definition of these cells 
as “site-regulated, multidrug dispensaries, or injury drugstores” 
(Caplan and Correa, 2011).
It was also demonstrated that the intrinsic capacity of MSCs 
to activate endogenous regenerative mechanisms and to induce 
the mobilization of host cells was critically dependent on their 
commitment level, highlighting the importance of carefully 
investigating differences in the soluble morphogens used as 
culture medium supplements. The addition of basic-fibroblast 
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growth factor (bFGF or FGF-2) to primary bone marrow-derived 
MSC cultures was a key element to select in vitro specific MSC 
subpopulations with potential to induce a host regenerative 
response in vivo (Tasso et al., 2012).
Within the specific components present in the stem cell-
conditioned medium, much interest has gained the extracel-
lular vesicles released by cells (EV, including microvesicles and 
exosomes) (Camussi et  al., 2013; Quesenberry et  al., 2014). 
EV can transfer, in addition to proteins and lipids, also genetic 
information such as mRNA and microRNA (miRNA) (Phinney 
et al., 2015; Zhang et al., 2016). In particular, miRNAs are small 
non-coding RNA exerting on target cells a post-transcriptional 
regulation of proliferation, differentiation, and death. Indeed, it 
was suggested that stem cells promote healing and tissue regen-
eration at the injury site also by delivering specific transcripts to 
target cells via EV. Extracellular vesicles have the advantage of (i) 
being immunologically inert, (ii) having the capacity to carry a 
significant amount of bioactive molecules, (iii) protecting them 
from enzymatic degradation because of the lipid bilayer and, at 
the same time, (iv) being able to transfer them to other cells by 
bypassing the hydrophobic membrane barrier. Therefore, EV 
have all properties for being an almost ideal vehicle for paracrine 
therapy.
Recent studies indicated that the cross talk between MSCs and 
cells of the innate immunity could be carried out by secreted EV. 
In particular, EV isolated from the conditioned medium of MSC 
harvested under both normoxic and hypoxic culture conditions 
acted as mediators of the dynamic interplay between MSCs and 
cells of the innate immunity both in vitro and in vivo in a mouse 
model of skeletal muscle regeneration (Lo Sicco et al., 2017). EV 
effectively triggered the macrophage proliferation and polariza-
tion from an M1 to an M2 phenotype. More recently, we provided 
the first characterization of hAFS-secreted extracellular vesicles 
as paracrine mediators endowed with regenerative miRNAs and 
supporting pro-survival, proliferative, and anti-inflammatory 
effects on target cells (Balbi et  al., 2017). The hypoxic precon-
ditioning induced an intensified release of EV enriched with 
miRNAs involved in different stages of the healing process. 
Direct administration of EV in a cardiotoxin-induced skeletal 
muscle injury reduced the inflammatory response, upregulated 
key markers of alternative activation patterns, and accelerated the 
expression of myogenic markers.
Interestingly, exosomes released in the extracellular compart-
ment were identified as one of the effectors also of platelet activity 
(Torreggiani et al., 2014).
UNLOCKiNG THe HiDDeN POTeNTiAL  
OF eNDOGeNOUS PROGeNiTORS
From studying limb regeneration in amphibians and observing 
the few regenerative models in mammals, including humans, we 
learned that the process leading to complete tissue regeneration 
can occur through paracrine signals recruiting to the wound site: 
(i) bone marrow-derived and tissue-specific stem/progenitor 
cells and (ii) de-differentiated cells deriving from lineage com-
mitted cells.
Activation and Mobilization of Tissue 
Resident Progenitor Cells
Pericytes are perivascular multipotent cells found in close rela-
tion to the walls of small blood vessels within connective tissues 
(Bergers and Song, 2005). They are a heterogeneous population 
with specific differences depending on their embryonic origin 
(neuroectodermal or mesodermal) and the type of vessels 
(venules or capillaries) they reside in. Markers used to identify 
pericytes, such as alpha smooth muscle (αSMA), PDGF recep-
tor (PDGFRβ), chondroitin sulfate proteoglycan 4, CD146, 
NG2, and others, are differently distributed among the pericyte 
population also related to their anatomical location (Armulik 
et al., 2011). Most of these markers are not exclusively expressed 
by pericytes, thus their specific isolation depends on the co-
expression of different markers. Several studies have shown that, 
in addition to stabilize vessels, pericytes perform other functions 
such as controlling vessel development, maturation, and perme-
ability, regulating blood flow and coagulation, maintaining the 
blood–brain barrier, and regulating phagocytosis and lympho-
cyte activation (Goodkin and Benning, 1990; Fabry et al., 1993; 
Geevarghese and Herman, 2014), as well as playing a major role 
in regeneration and repair of several tissues in response to injury 
(Birbrair et al., 2015). All vascularized tissues contain pericytes 
exhibiting progenitor properties, but the in  vivo potential and 
developmental interactions between pericytes, mesenchymal 
stem/stromal cells, and tissue-specific progenitors, remain mostly 
unknown. Notably, pericytes have been considered similar to 
MSCs since they express some of the MSC markers both in vitro 
and in  vivo. As blood vessels are present in almost all organs, 
it was also suggested that pericytes correspond to tissue-specific 
adult stem cells (Sacchetti et  al., 2007; Caplan, 2008; Corselli 
et al., 2010). Even though pericytes are key players and regula-
tors of vascular morphogenesis and their anatomical apposition 
and their sharing the same basement membrane ease interactions 
between pericytes and endothelal cells, the pericyte role is not 
fully understood. A collection of articles on nature and functions 
of pericytes and their in situ activation for tissue regeneration/
repair was very recently published (Madeddu and Peault, 2017). 
Pericyte regenerative potential has been exploited for therapy 
of several pathologies, including cancer. Given their adapt-
ability for applications of tissue engineering, pericytes were also 
proposed for the repair of several tissues and organs, including 
vascular grafts, skeletal muscles, heart, skin, bone, and cartilage. 
Moreover, pericytes were applied in diverse orthopedic models, 
both ectopic and orthotopic. Pericyte implantation resulted in 
improved tissue healing by both direct and indirect mechanisms. 
Several studies are presently being performed on factors released 
by pericytes, including cytokines, microRNA, and microvesicles, 
that are possibly involved in the cross talk between pericytes and 
other cell types.
However, in contrast to the many positive effects induced by 
the pericyte activation, in some cases, the extreme adaptability of 
these cells could be a brake to tissue regeneration and repair. A 
recent study by Dulauroy et al. (2012) identified a pericyte derived 
myofibroblast progenitor by the expression of the cell membrane-
associated protease, ADAM12, and revealed a significant role 
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for this progenitor in the tissue fibrosis observed after skin and 
skeletal muscle injury. The genetic ablation of ADAM12 inhibited 
fibrosis, prevented the formation of a scar acting as a barrier 
precluding interactions of epithelial and underlying cells thus 
impairing the neo-tissue formation, and allowed tissue repair.
Recruitment of Circulating Stem/
Progenitor Cells with Healing Potential
The idea of adult stem cells behaving as cell progenitors restricted 
to their tissue of origin and being the only ones involved in tissue 
regeneration must be reconsidered. Several publications report 
that, in response to a tissue damage and under the influence of 
various pathological stimuli, tissue-specific or bone marrow-
derived stem/progenitor cells are mobilized to the PB and migrate 
to the wound site, where they exert a master role during wound 
healing, being directly involved or by enhancing the activation 
of resident cells. All stem/progenitor cells from the PB described 
so far, were specifically isolated in pathological conditions or fol-
lowing exogenous stimulation such as using mobilizing factors 
(Otsuru et al., 2008; Ciraci et al., 2011). Hematopoietic stem cells 
are the archetype of resident stem cells that can be mobilized 
and used for transplantation therapies (Copelan, 2006). EPCs 
circulating in the PB are effectively involved in angiogenesis and 
vasculogenesis processes (Basile and Yoder, 2014) although they 
present restricted differentiation capacity.
The presence of very small-sized stem cells with pluripotent 
characteristics in the bone marrow and other adult organs was 
reported (Kucia et al., 2006). However, the real existence of such 
cell population is very controversial, possibly due to debatable 
flow cytometry analysis and the adopted cell isolation procedures 
(Miyanishi et al., 2013), and there was no evidence for the pres-
ence of stem/progenitor cells of mesenchymal nature circulating 
in the PB in physiological conditions. Recently, we reported the 
identification of a rare cell population of circulating cells derived 
from the PB of healthy mice and actively participating in the 
healing process (CH cells) (Lo Sicco et  al., 2015). Indeed, CH 
cells behaved as connective tissue precursors able to integrate in 
wounded tissues and to appropriately differentiate into a broad 
spectrum of tissue-specific cells. These progenitor cells were iden-
tified as small cells characterized by the pan-hematopoietic CD45 
antigen lack of expression, as well as of the markers expressed by 
differentiated blood cells, and of markers typically associated with 
well-defined progenitors circulating upon injury. The analysis of 
the global transcriptional profile of the purified CH cells revealed 
the expression of markers expressed also by epiblasts during the 
embryogenesis process. As a whole, our findings support the con-
cept of CH cells as key effectors of the body innate regenerative 
potential and suggest new ways of approaching tissue regenera-
tion. In light of this study, one can also consider the intriguing 
possibility that a specific recruitment of endogenous progenitors 
with mesenchymal characteristics could guaranty the physiologi-
cal cell turnover in connective tissues throughout the lifespan 
of the individual and, at the same time, enhance tissue repair or 
regeneration when a tissue injury occurs. However, this hypoth-
esis could open a completely new field of research and additional 
extensive investigations are required to confirm the hypothesis.
Reprogramming of Tissue Differentiated 
Cells
As stated before, amphibians are good models to investigate 
mechanisms of tissue and organ regeneration. We already 
mentioned how, for limb regeneration, the newt switches from 
a juvenile stem/progenitor-based process to an adult dedifferen-
tiation-based mode where cells from the different limb tissues 
strictly regenerate the same type of tissues (Tanaka et al., 2016). 
Another well-known example of organ regeneration, through 
reprogramming of differentiated cell, is the zebrafish heart. This 
organ can fully regenerate in few weeks following severe injury 
by the activation of resident cardiac progenitor cells influencing 
the dedifferentiation, proliferation, and maturation of the surviv-
ing cardiomyocytes (Lepilina et  al., 2006). However, although 
cellular and molecular mechanisms of regeneration are currently 
being investigated also in a variety of other contexts (Tanaka and 
Reddien, 2011), our understanding of epigenetic reprogramming 
occurring during regeneration is only at the beginning (Katsuyama 
and Paro, 2011). Indeed, a heated debate is still going on about 
the hypothesis that, in mammals including humans, after a tissue 
injury, differentiated cells can revert to a pre-differentiation stage, 
proliferate, and contribute to the restoration of the tissue of origin, 
in addition to the canonical view that tissue resident or recruited 
stem/progenitor cells are responsible of regenerative effects. 
However, although sometimes the two mechanisms have been 
presented as mutually exclusive, actually they can co-exist and 
can act synergistically. Indeed, there is a rising evidence that both 
mechanisms (i) local induction of proliferation of progenitor/stem 
cells (Crisan et al., 2011; Chen et al., 2015; Sacchetti et al., 2016) and 
(ii) dedifferentiation, proliferation, and reprogramming of mature 
differentiated or committed cells (Jopling et  al., 2011; Riddell 
et al., 2014; Szibor et al., 2014; Tarlow et al., 2014; Wahlestedt and 
Bryder, 2014) play a role in the repair/regeneration of damaged 
tissues also in mammals, contributing with a major or minor role, 
depending on the individual age. In particular, in humans, recent 
evidence from studies on phenotype conversion and proliferation 
of cardiomyocytes in postnatal life (Zacchigna and Giacca, 2014; 
Kimura et al., 2015) as well as adult endochondral (von der Mark 
and Zhou, 2016) and articular (Jiang et al., 2016) chondrocytes 
indicates that replication of already differentiated cells might play 
a critical role during tissue and organ healing, on top of recruit-
ment and activation of stem/progenitor cells.
In our group, we investigated the effect of the factors present 
in the PL on reprogramming differentiated cells either with or 
without concomitant presence of inflammatory cytokines, using 
cultures of confluent terminally differentiated human cells, in a 
stage of basic metabolism as a model. PL induced an initial pro-
inflammatory response along with an increased migratory capac-
ity on a keratinocyte cell line (El Backly et al., 2011). Moreover, 
following PL stimulation, chondrocyte otherwise not responding 
to standard culture conditions (fetal calf serum supplement) 
responded with a strong induction of proliferation while main-
taining their chondrogenic potential (Pereira et  al., 2013). In 
quiescent osteoblasts, PL triggered an initial pro-inflammatory 
activity along with IL-6, IL-8 secretion, and simultaneous induc-
tion of COX-2 and PGES, eventually leading to PGE2 synthesis 
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and resolution of inflammation (Ruggiu et al., 2013). The inflam-
matory phase was paralleled by cell morphology changes and a 
cell cycle re-entry leading to cell proliferation. PL stimulated cells 
reached confluence at a higher cell density still retaining their 
differentiation capability.
Pharmacological induction of Tissue 
Regeneration
The long-term goal of regenerative medicine is to adopt cell-
inspired strategies to identify ideal drug formulation in order to 
mimic the physiological inducers of tissue healing and regenera-
tion so to mobilize the different cell players mastering these pro-
cesses. This will allow a large-scale production of “off the shelf ” 
therapeutic agents for tissue repair and regeneration, with major 
benefits for a large number of patients. Research in this area is 
still in its infancy and very few sporadic reports on drug-induced 
activation of genes and pathways involved in tissue regeneration 
exists (Zhang et  al., 2015; Zhao et  al., 2015; Fan et  al., 2016). 
However, these potentially high potent agents being associated 
with a series of possible and still partly unknown risks, major 
investments in basic science, preclinical, and clinical studies are 
needed before this ambitious goal could be reached.
CONCLUSiON
Despite the big interest of the scientific and medical community 
in the possibility of restoring the body endogenous regenerative 
potential following an injury and the increasing number of reports 
on this topic, further studies are needed in order to pinpoint 
specific mechanisms and discrete masters regulators needed to 
obtain true tissue regeneration, on top of basic repair. Eventually, 
by identifying the relevant signaling pathways and the key mol-
ecules involved, we will be able to envisage an advanced medicinal 
product to be exploited for future regenerative medicine.
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